Update of liver fibrosis and steatosis with transient elastography (Fibroscan)

por Wong, Grace Lai-Hung
Publicado 2013

Prediction of fibrosis progression in chronic viral hepatitis

por Wong, Grace Lai-Hung
Publicado 2014

Management of chronic hepatitis B patients in immunetolerant phase: what latest guidelines recommend

por Wong, Grace Lai-Hung
Publicado 2018

Tips for Responding to Reviewers’ Comments–from an Editor’s or Reviewer’s Points of View

por Wong, Grace Lai-Hung
Publicado 2019

Drug-drug interactions with direct-acting antivirals — less is more

por Wong, Grace Lai-Hung
Publicado 2021

Unmet need in chronic hepatitis B management

por Liang, Lilian Yan, Wong, Grace Lai-Hung
Publicado 2019

The truth of the matter: will immune-tolerant chronic hepatitis B patients benefit from antiviral treatment?

por Jeng, Wen-Juei, Wong, Grace Lai-Hung
Publicado 2023

Application of transient elastography in nonalcoholic fatty liver disease

por Zhang, Xinrong, Wong, Grace Lai-Hung, Wong, Vincent Wai-Sun
Publicado 2020

Personalized management of cirrhosis by non-invasive tests of liver fibrosis

por Wong, Grace Lai-Hung, Espinosa, Wendell Zaragoza, Wong, Vicnent Wai-Sun
Publicado 2015

Secondary prevention for hepatocellular carcinoma in patients with chronic hepatitis B: are all the nucleos(t)ide analogues the same?

por Yip, Terry Cheuk-Fung, Lai, Jimmy Che-To, Wong, Grace Lai-Hung
Publicado 2020

Reply

por Wong, Grace Lai-Hung, Hui, Vicki Wing-Ki, Yip, Terry Cheuk-Fung
Publicado 2023

Negligible risk of hepatocellular carcinoma in chronic hepatitis B patients in immune-tolerant phase: Myth or fact

por Yip, Terry Cheuk-Fung, Wong, Grace Lai-Hung, Wong, Vincent Wai-Sun
Publicado 2021

Alanine Aminotransferase Level: The Road to Normal in 2021

por Yip, Terry Cheuk‐Fung, Wong, Vincent Wai‐Sun, Wong, Grace Lai‐Hung
Publicado 2021

Management of hepatitis B virus reactivation due to treatment of COVID-19

por Yip, Terry Cheuk-Fung, Gill, Madeleine, Wong, Grace Lai-Hung, Liu, Ken
Publicado 2022

Epidemiology and Clinical Outcomes of Metabolic (Dysfunction)-associated Fatty Liver Disease

por Lin, Huapeng, Zhang, Xinrong, Li, Guanlin, Wong, Grace Lai-Hung, Wong, Vincent Wai-Sun
Publicado 2021

Moving toward hepatitis B virus functional cure - the impact of on-treatment kinetics of serum viral markers

por Liang, Lilian Yan, Wong, Vincent Wai-Sun, Wong, Grace Lai-Hung, Yip, Terry Cheuk-Fung
Publicado 2023

Non-invasive tests of non-alcoholic fatty liver disease

por Li, Guanlin, Zhang, Xinrong, Lin, Huapeng, Liang, Lilian Yan, Wong, Grace Lai-Hung, Wong, Vincent Wai-Sun
Publicado 2022

Two different types of COVID-19 vaccines and serial liver biochemistries

por Wong, Grace Lai-Hung, Hui, Vicki Wing-Ki, Yip, Terry Cheuk-Fung, Tse, Yee-Kit, Wong, Vincent Wai-Sun
Publicado 2022

Three COVID-19 medications-remdesivir, molnupiravir and ritonavir-boosted nirmatrelvir-and serial liver biochemistries in 22, 456 subjects

por Wong, Grace Lai-Hung, Hui, Vicki Wing-Ki, Yip, Terry Cheuk-Fung, Tse, Yee-Kit, Wong, Vincent Wai-Sun
Publicado 2022

Non-invasive biomarkers for liver inflammation in non-alcoholic fatty liver disease: present and future

por Yip, Terry Cheuk-Fung, Lyu, Fei, Lin, Huapeng, Li, Guanlin, Yuen, Pong-Chi, Wong, Vincent Wai-Sun, Wong, Grace Lai-Hung
Publicado 2023